title: Reply from authors re: Jean-Nicolas Cornu. Overactive bladder medical management in the elderly: it is time to go beyond the tip of the iceberg. Eur Urol 2013;64:82-3.
authors: University of Alberta, Edmonton, Canada. adrian.wagg@ualberta.ca
authors: Adrian
authors: A
authors: Wagg
authors: Mark
authors: M
authors: Dale
authors: Reiner
authors: R
authors: Tretter
authors: Bridget
authors: B
authors: Stow
authors: Gerhard
authors: G
authors: Compion
mesh_terms: D000375:Aging / Q000523:psychology*; D003071:Cognition / Q000187:drug effects*; D060825:Cognitive Dysfunction / Q000150:complications*; D005260:Female; D006801:Humans; D008297:Male; D008333:Mandelic Acids / Q000627:therapeutic use*; D018727:Muscarinic Antagonists / Q000627:therapeutic use*; D011812:Quinuclidines / Q000627:therapeutic use*; D000069464:Solifenacin Succinate; D044005:Tetrahydroisoquinolines / Q000627:therapeutic use*; D053201:Urinary Bladder, Overactive / Q000188:drug therapy*; D064804:Urological Agents / Q000627:therapeutic use*
chemical_list: D008333:Mandelic Acids; D018727:Muscarinic Antagonists; D011812:Quinuclidines; D044005:Tetrahydroisoquinolines; D064804:Urological Agents; C005419:oxybutynin; D000069464:Solifenacin Succinate